FDA Warns AstraZeneca on 'Misleading Claims' About COPD Drug
Claims that Breztri has been shown to reduce risk of death in COPD patients are not supported by clinical data, the agency says.
Source: medscape.com
Stay updated with breaking news from Beta Adrenergic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Claims that Breztri has been shown to reduce risk of death in COPD patients are not supported by clinical data, the agency says.